<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 347 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page346.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=347">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 347 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 347</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=347"><img src="../thumb/347.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>310 / 2020-04                                                           Endocrine System - 19.8
   (S4) INJ, R/21.12/184        riph.oed., asthen., thrombocytopen., leukopen., lymphocyt.decr.esp.  osteoporos., fract., pain in limbs, osteoarthrit., myalg., joint stiffn.,
   792462-009: 300 mg/3 ml, 3x3 ml amps, R874,06  wih pre-exist. lymphopen., liv.enzyme elev., assess bone min. den-  fatig., periph. oed., asthen., elev.liv.enzym.
   Dosage: Deep IMI admin.      sity of pts.with osteoporos./at risk thereof. reg. & treat as appropr.  Special precautions: Assess bone min.density of pts.with oste-
   Male drive reduct.in sex.deviations: 1 amp every 10-21 days   Warnings and special precautions: Confirm post menopaus.  oporos./at risk init.& reg.dur.ther., osteoporos. prophylax.treatm.init.
   incr.to 2 amps in except. cases. Effic.maint.by inj.interv.of 10-21   status by LH, FSH & oestradiol lev., not recomm.in childr., assess.  as appropr.& monit., concom.agents that are substrat.for CYP3A4
   days. Once satisfact. therapeut.respons.obtain.try & reduc. dos.   bone miner. density when init.treatm.& at reg.interv.thereaft, init.   /narr.therap.index., not recomm.in childr., confirm post menopaus.
   by incr. interv. Admin.over protact.time in conjunct. with psycho-  osteoporos.treatm./prophylax.when necess., concom. oestrog.con-  status by LH/FSH & oestrad. lev., hepat./ren.impairm., lact.intol.,
   therapeut.meas.              tain.meds.as pharmacolog. act. negat.  cont. sucrose & mannitol
   Inop.prostat. Ca. Aft.orchidect: 300 mg every 2 wks. Without   Drug interactions: Reduc.plasma conc./effic.with CYP 3A4 induc.
   orchidect: 300 mg wkly. Do not interrupt. treatm.or reduc.dos.  ASPEN BROMOCRIPTINE, (Aspen Pharmacare: Pharma)   e.g.rifampicin/phenytoin/ carbamazepine/ St John’s Wort.
   aft.improvem./ remiss.       Pharmacare [P/S]
   Contraindications: Liv.dis., Dubin Johnson/ Rotor syndr., prev./ex-  Bromocriptine   AVODART, GSK &
   ist.liv.tumours (if not due to Ca prostate metastas.in men), wasting   Indications: Puerp.lactat.prevent./suppress.for medic.reas., men-  Dutasteride
   dis.except Ca prostate, depress., prev./exist. thrombo-embol. pro-  str.cycle disords./fem.infertil. assoc. with hyperprolactinaem.,   Indications: Benign prostat.hyperplas.
   cess., sev.diab.with vasc.chang., sickle-cell anaem.  hyperprolactinaem. in men, prolactinomas, acromegaly adjunct.,   (S4) SOFT GEL CAPS, 37/21.12/0282
   Side effects: Dos.relat.direct hepat.toxic.incl. jaund./hepatit.& liv.  Parkinson’s dis.  703202-001: 0,5 mg, 30, R616,75
   fail.with fatalit., liv.tumours, shortn.of breath at high dos., thrombo-  (S4) TABS, [P/S] 30/21.12/0459  Dosage: Adult males incl.elderly: 1 cap.once dly.
   embol. events., changes in RBC numb., hypersens., reduc. adreno-  704593-001: 2,5 mg, 30, R387,64  Contra-indications: Other 5 alpha-reduct. inhibit. hypersens.,
   cortic.funct., incr.prolact.lev., weight incr./ decr., decr.libido, erect.  Dosage: Admin.with food.  women, childr.
   dysfunct., depress., restlessn., skin rash, osteoporos., revers.inhib-  Lactat.inhibit: Admin.soon aft.parturit.as poss. 1 st  tab.within 1   st  Side-effects: 50% decr.in ser.PSA levels aft.6 mnths.ther., impot.,
   it.of spermatogen., gynaecomast., feel.of tens.in breasts, enlarg.  8 hrs.of deliv., foll.by1 tab.2xdly.x 2 wks.  decr.libido, ejaculat.disords., gynaecomast.
   mamm.glands, galactorrh, benign nodul., fatig., hot flush., sweat.  Suppress.est.lactat.: 1 tab.dly.x2-3 days.foll.by 1 tab.2xdly.x2 wks.   Special precautions: 6 mnths.ther.for object. assesm., hepat.im-
   Special precautions: Do not give bef.conclus.of puberty, monit.liv.  Resum.for furth.week if milk secret.re-occurs tak.1 tab.dly.  pairm.eff.not stud.but caut. advis. in liv.dis., as absorp.through skin
   funct.pre-treatm.& if S&S suggest. of hepatotoxic.occur ther.should   Menstr.cycle disords.& hyperprolactinaem. assoc.fem.in-  wash affect. area immed., PSA baseline &lt;4 ng/ml when on ther.
   norm.be discont., cons.risk:benef.ratio if hepatotox.confirm. by an-  fertility: 1,25 mg at bedt. x3days, then 2,5 mg at bedt. x3 days,   does not excl.prostate Ca diagn.
   other cause eg metastat.dis., sex.steroids can promote growth of   then 2,5 mg 2xdly. Dos.may be incr.to 2,5 mg 3xdly & if need.by a   Drug interactions: Bld conc.may incr.in pres.of CYP3A4 inhibit.
   cert.horm.depend.tiss.& tumours., consid.shortn.of breath poss.due   furth.2,5 mg dly at 2-3 day interv. Most respond to 7,5 mg dly.but   See also MDR page 357.
   to stimulat.eff.of progesterone & synthet. progesterone on breath.,   up to 30 mg/day has been used. May cont.treatm.over equiv.of sev.   BICALOX, Litha [P/S]
   incr.risk of thromboembol. events with prev.hist.thereof/CVA hist./  menstr. cycles to prev.relaps.  Bicalutamide.
   advanc.malign., caref.risk:benef.eval.in prostat. Ca pts.with thrombo-  Prolactinomas: 1,25 mg 2-3xdly. grad.incr.to max.of 20 mg dly. as   Indications: Advanc.prostate Ca in combin.with LHRH analogue
   embol.hist.&/ sickle-cell anaem./diab.with vasc.chang., incr.prolact.  reqd.to contr.plasma prolactin.levs.  ther./surg.castrat.
   lev. with high dos., reduc.sex.drive/potency & inhibit. gonad.funct.is   Acromegaly adjunct: Init.1,25 mg 2-3xdly.grad. incr.to 10-20 mg   (S4) TABS. 41/21.12/0818
   revers.on discontin., CV dis., ischaem. heart dis., cerebrovasc.dis.,   dly.depend.on clinic.respons.& S/E. Est.correct dos.accord.to   712506-001: 50 mg, 30, R608,32
   hypertens., monit.adrenocortic.funct. & RBC count, strict med. su-  growth horm.lev.  Dosage: Begin 3 days bef.LHRH ther./same time as surg.castrat.
                                                      st
   pervis.of diab., alcoh.diminish.sex.drive reduct. eff.  Parkinson’s: Init. 1,25 mg/day pref.in even.over 1  wk., incr.dly.  Adult males incl.elderly: 1 tab once dly.
   Interactions: Oral antidiab./insul.requirm.may change, strong CY-  dos.grad.by increm.of 1,25 mg a day every wk., div.dly.dos.into 2-3   Contraindications: Fem., childr., pregn.& lactat.
   P3A4 inhibit.metabol., CYP3A4 induc.may reduc.lev., statin assoc.   sngl.dos. Adeq. respons.poss.within 6-8 wks., otherwise the dos.   Side effects: Freq: Asthen., hot flush., diarrh., constip., naus,
   myopathy /rhabdomyolys.incr.  may be further incr.by increm.of 2,5 mg/day every wk. Dly.dos.to   musc.& joint weakn., prurit., dry skin, cough, hoarsen., runny nose,
                                be reduc.& maint.constant x1 wk.at least, if undesir.reacts.occur
   ARIMIDEX, AstraZeneca        dur.titrat. If advers. effs. disappear dos.may be incr.again. Usual   shortn.of breath, sore throat. Less freq: Headache, fev., chills,
   Anastrozole.                 monother. therapeut.range: 10-40 mg/day. High. dos. may be reqd.  thrombocytopen., anaem., hypertens., gynaecomast., breast ten-
   Indications: Early & advanc.breast Ca in postmenopaus. women.   Contraindications: Ergot alkaloid hypersens., pregn., safety &   dern., ment.depress., nervousn., dizzin., confus., drowsin., insomn.,
   Effic.not demonstrat.in oestrog.recept.negat.pts.unless prev.posit.  effic.in childr.not est., sympts./ hist. of ser.psychot.disords., hepat.  somnol., bloat.feel., indigest., GI/rect.bleed, vomit., dry mouth, loss
   clinic. respons.to tamoxifen report.  dis., sev.angina, MI, eclamps., uncontr.hypertens., post part., puer-  of appet., flatul., oed., impot., hepatit., jaund., cholestat.jaund., skin
   (S4) TABS. 30/21.12/0495.    per. woman with high BP, coron.artery dis., concom. ergot.alkaloids.  rash/ itch., dyspn., tight chest, flu-like syndr., chest pain. Unknown
   824224-019: 1 mg, 30, R1 952,53  Side effects: Hypertens., MI, seiz., stroke, psychos. with hallucin./  freq: Pain, abdom./chest/ pelv. pain, leucopen., neutropen., angina,
   Dosage: Adults incl.elderly: 1 tab.once dly.  delus.& confus., sev. headache, trans.vis.disturbs., hypotens.esp.  HF, conduct.irregularit.incl. PR & QT-interv. prolongat., arrhythm.,
   Contraindications: Pre-menopaus.women, pregn. & lactat., sev.  on init., orthostat. hypotens., retroperiton. fibros.esp.on long-term   non-specif. ECG changes, haematolog.disords., decr.libido, diab.
   ren.impairm., mod.to sev. hepat.dis.  high dos.treatm., pleur.thickn./effus., postur. hypotens., GI bleed.in   mellit, hyperglycaem., weight gain/loss, anorex., neurologic. disord.,
   Side effects: Hot flush., asthen., joint pain/stiffn., trigger finger,   acromegaly.pts., CNS effs., vis. disturbs., GI disturbs.incl.bleed.&   noctur., urine discol., methaemoglobinaem., transaminas.lev.elev.,
   vag.dryn./bleed, hair thin., rash, GI disturbs., headache, carpal.tun-  gastric ulc., alt.liv.funct.test, arrhythm., leg cramps, nas.congest.,   alopec., sweat., hirsut., hypersens.reacts., malaise, blurr.vis., anx.
   nel syndr., hypercholesterolaem., somnol., erythem. multiforme,   dry mouth, dyston.in Parkinsonism, erythromelalg., ang.exacerbat.,   Warnings and special precautions: Mod.to sev. hepat. impairm.,
   Stev.Johns.syndr., allerg.reacts.incl. angio-oed.& anaphylax., urticar.,   micturit., muzzin., revers. pall.of fingers & toes esp. pts.prev.exhibit.  period.liv.funct.tests advis., meds. metabol.by cytochrome P450,
   hepatobil. disords. incl.hepatit., thromboembol., fluid retent., dizzin.,   Raynauds, syncope.  monit. prothromb. time with concom.coumar.anticoags.
   ischaem. CV events partic.in pts.with pre-exist. ischaem.heart dis.  Special precautions: Psychot.disord.hist., sev.CV dis., pept.ulc.  Interactions: Concom.meds.that may inhib. oxidat. of agent
   Special precautions: As Arimidex low.circulat. oestrog. lev.poss.  hist., GI bleed, monit BP in postpartum pts., concom.BP alter.meds.,   eg.ketoconazole & cimetidine which could theoretic.incr.plasma
   reduct.in bone min.density with conseq. incr.fract.risk, biochem.con-  discont.if hypertens./ unremit. headache/other signs CNS toxic.   conc., poss. displac. warfar.from its prot.bind.sites., midazolam
   firmat.of menopause if in doubt., consid.furth.eval.of persist. vag.  develop, withdr.if fibrot.chang.in retroperitoneum. diagn./suspect.,   expos.incr.
   bleed., no clinic.informat.on other concom. anti-cancer agents use,   pleuropulm. disords., rule out poss.pituit.adenoma bef.treat., hy-  CALOXA 50 mg Eurolab [P/S]
   not recomm.in childr.        perprolactinaem. with/without amenorrh., ovulat. in women with
   Drug interactions: Tamoxifen &/other oestrog. contain. ther.  amenorrh.& galactorrh. poss, appropr.contracept.meas.when reqd.,   Bicalutamide.
                                                              Indications: Advanc.prostate Ca in combin. with LHRH analogue
   would dimin.pharm.act.       assess. & treat. acromegaly pts.only if alternat.to convent. ther. reqd.,   ther./surg.castrat.
   AROMASIN, Pfizer             alternat.treat.in acromegaly.pts with hist. pep.ulcerat., low.effect.  (S4) TABS. 42/21.12/0430
   Exemestane                   dos.for sympt.contr.of condits.in women not assoc.with hyperpro-  715721-001: 50 mg, 30, R573,87
   Indications: Advanc.oestrog.recept.posit. breast Ca in natural/  lactinaem. to avoid suppress.prolactin bel. norm. lev.with conseq.  Dosage: Begin 3 days bef.LHRH ther./same time as surg.castrat.
   induc.postmenopaus.status where dis. progress.follow,anti-oes-  impairm.of luteal funct., assess post-ovulat.progester.& plasma pro-  Adult males incl.elderly: 1 tab once dly.
   trog.ther., adjuv. treatm. of oestrog.recept.posit.invas.early breast   lact. levs. if treatm.contin more than 6 mnths., discont. when pregn.  Contraindications: Fem., childr., safety in pregn.& lactat.not est.
   Ca dis. free postmenopaus.women follow.at least 2 yrs. init.ad-  confirm.in pts.wish.to conceive unless medic. reas.for contin., clos.  Side effects: Anaem., leucopen., neutropen., thrombocytopen.,
   juv.tamoxifen ther.          observ.throughout pregn. of pituit.adenoma pts.fall.pregn while rec.   hypersens.reacts.incl. angioed., anorex., diab.mellit, hyperglycaem.,
   (S4) TABS, 35/21.12/0011     treatm. & ther.stop., reinstat.ther./consid.surg. appropr. in pts.show.  depress., dizzin., somnol., insomn., nervousn., drowsin., confus., hy-
   700482-003: 25 mg, 30, R1 785,32  sympts.of pronounc.enlargem. of prolactinoma, reg.gynaecolog.as-  pertens., URTI, cough, hoarsen., shortn.of breath, sore throat, sneez.,
   Dosage: Adults & elderly: 25 mg dly.pref.aft.a meal. In adv.breast Ca   sessm.of pts rec. ther.more than 6 mnths., period.liv.funct.test. in   interstit. lung dis., dyspn., abdom./chest pain, GI disturbs., GI/rect.
   cont.until tumour progress. evid. In early breast Ca contin. treatm. un-  long term treatm., lact.intol.  bleed., hepat.chang./fail., methaemoglobinaem., alopec., hirsut.,
   til 5 yrs.of adjuv.hormon.ther.completed/until tumour relapse occurs.  Drug interactions: Reduc.in BP, alcoh.reduc.tol., erythromyc   dry skin, sweat., prurit., skin rash, haematuria, noctur., gynaeco-
   Contraindications: Pre-menopaus.women, pregn. & lactat.  incr.plasma lev., dopamine antagon. may reduc.prolactin-low.eff.  mast., breast tendern., impot., decr. libido, asthen., oed., fev., chills,
   Side effects: Hot flushes, fatig., insomn., depress., headache, diz-  ASPEN EXEMESTANE, (Aspen Pharmacare) Pharmacare  flu-like syndr., weight gain.
   zin., carpal tunnel syndr., somnol., hot flushes, anorex., GI disturbs.,   Exemestane  Special precautions: Cont.lact., mod.to sev. hepat.impairm., pe-
   incr. sweat., skin rash, alopec., joint & musculoskelet. pain, pain, pe-  Indications: Advanc.oestrog.recept.posit.breast Ca in natural/in-  riod.liv.funct.tests esp.with longt.treatm., discont.treatm.in case of
                                duc.postmenopaus.status where dis. progress.follow.anti-oestrog.
                                ther., adjuv. treatm. of oestrog.recept.posit.invas.early breast Ca
            Side effects        dis. free postmenopaus.women follow.at least 2 yrs.of init.adjuv.
                                tamoxifen ther.
         refer only to those    (S4) TABS, 46/21.12/0157            Hypersensitivity to the
                                721738-001: 25 mg, 30, R1 312,23
          which occur at        Dosage: Adults & elderly: 25 mg once dly.pref. aft.a meal. In   ingredient(s)=components
                                advanc.breast Ca cont.until tumour progress. evid. In early breast
         the recommended        Ca contin. treatm. unt.5 yrs.of adjuv.hormon.ther.complet./ until tu-  of any medicine contra-
           dosages and          mour relapse occurs.                   indicate its use.
                                Contraindications: Pre-menopaus.women, pregn. & lactat., con-
          correct route of      com.oestrog.contain.meds.
                                Side effects: Infect., URTI, UTI, flu-like sympt., bld. dyscras., ano-
          administration.       rex., psych.disords., headache, dizzin., carpal tunnel syndr., somnol.,
                                dyspn., bronchit., back/chest pain, sinusit., pharyngit., rhinit., GI dis-
                                turbs., hepatit., cholest.jaund., skin rash, itch., alopec., paraesthes.,
                                joint & musculoskelet. pain incl.arthralg., bone min. density reduct.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page346.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page342.html">342</a>&nbsp;&nbsp;&nbsp;<a href="page343.html">343</a>&nbsp;&nbsp;&nbsp;<a href="page344.html">344</a>&nbsp;&nbsp;&nbsp;<a href="page345.html">345</a>&nbsp;&nbsp;&nbsp;<a href="page346.html">346</a>&nbsp;&nbsp;&nbsp;<a href="page347.html">347</a>&nbsp;&nbsp;&nbsp;<a href="page348.html">348</a>&nbsp;&nbsp;&nbsp;<a href="page349.html">349</a>&nbsp;&nbsp;&nbsp;<a href="page350.html">350</a>&nbsp;&nbsp;&nbsp;<a href="page351.html">351</a>&nbsp;&nbsp;&nbsp;<a href="page352.html">352</a>
             </td>
             <td width="35%"><a href="page348.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page348.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
